Evidence map›Paper›PMID 23649979›Full record

ArticleAnnals of biomedical engineering2013

High sensitivity micro-elastometry: applications in blood coagulopathy.

Gongting Wu, Charles R Krebs, Feng-Chang Lin, Alisa S Wolberg, Amy L Oldenburg

Abstract read
In one paragraph

Article in Annals of biomedical engineering, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Fibrin mechanical properties and their structural origins.Matrix biology : journal of the International Society for Matrix Biology · 2017
    Review
  6. Article
  7. Article
  8. Article
  9. Magnetomotive Optical Coherence Elastography for Magnetic Hyperthermia Dosimetry Based on Dynamic Tissue Biomechanics.IEEE journal of selected topics in quantum electronics : a publication of the IEEE Lasers and Electro-optics Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gongting WuDepartment of Physics and Astronomy, University of North Carolina at Chapel Hill, CB 3255, Chapel Hill, NC 27599, USA.
Charles R Krebs
Feng-Chang Lin
Alisa S Wolberg
Amy L Oldenburg
University of North Carolina at Chapel Hill · US

Funding

Cellular Determinants of Fibrin Structure and StabilityR01HL094740 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WOLBERG, ALISA S. · 2009 to 2013
$1.6M
Novel Device for Sensitive, Small Sample Volume Assessment of Clot ElasticityR21HL109832 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI OLDENBURG, AMY L · 2011 to 2012
$371k
NHLBI NIH HHS R01 HL094740NHLBI NIH HHS R01HL094740NHLBI NIH HHS R21 HL109832NHLBI NIH HHS R21HL109832
6 · The paper itself

Abstract

Highly sensitive methods for the assessment of clot structure can aid in our understanding of coagulation disorders and their risk factors. Rapid and simple clot diagnostic systems are also needed for directing treatment in a broad spectrum of cardiovascular diseases. Here we demonstrate a method for micro-elastometry, named resonant acoustic spectroscopy with optical vibrometry (RASOV), which measures the clot elastic modulus (CEM) from the intrinsic resonant frequency of a clot inside a microwell. We observed a high correlation between the CEM of human blood measured by RASOV and a commercial thromboelastograph (TEG), (R = 0.966). Unlike TEG, RASOV requires only 150 μL of sample and offers improved repeatability. Since CEM is known to primarily depend upon fibrin content and network structure, we investigated the CEM of purified clots formed with varying amounts of fibrinogen and thrombin. We found that RASOV was sensitive to changes of fibrinogen content (0.5-6 mg/mL), as well as to the amount of fibrinogen converted to fibrin during clot formation. We then simulated plasma hypercoagulability via hyperfibrinogenemia by spiking whole blood to 150 and 200% of normal fibrinogen levels, and subsequently found that RASOV could detect hyperfibrinogenemia-induced changes in CEM and distinguish these conditions from normal blood.

Indexed as

Blood CoagulationElastic ModulusBlood Coagulation DisordersBlood Coagulation TestsFibrinFibrinogenHumansSensitivity and SpecificityFibrinFibrinogen

Identifiers

PMID23649979
PMCPMC3766428
OpenAlexW2146006326

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.